Diaphragmatic Myofascial Release for Hyperkyphotic Subjects

Response of Lung Function, Chest Mobility, and Kyphotic Curve to Diaphragmatic Myofascial Release in Hyperkyphotic Subjects: A Randomized Controlled Trial

kyphotic subjects have respiratory disturbances due to weakening of the diaphragm, responsible for inhalation, which lead to abnormalities in respiratory mechanics and abnormal gas exchange, leading to respiratory complications. Myofascial release of the diaphragm is an intervention intended to indirectly stretch the diaphragm muscle fibers to reduce muscle tension, normalize fiber length, and promote the efficiency of muscle contraction. Although diaphragm myofascial release has been used in clinical practice, to the best of the authors' knowledge, the current study is the first research investigating the effect of diaphragmatic myofascial release on lung function, chest mobility and kyphotic curve in hyperkyphotic subjects.

Study Overview

• Status: Not yet recruiting
• Conditions: Hyperkyphosis
• Intervention / Treatment: Other: diaphragmatic myofascial release with traditional physical therapy exercises for hyperkyphosis; Other: traditional physical therapy exercises for hyperkyphosis

• Study Type: Interventional
• Enrollment (Estimated): 42
• Phase: Not Applicable

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• The participant's age ranged from 20 to 40 years.
• kyphosis angle 40-50◦
• reporting pain on palpation of the diaphragm

Exclusion Criteria:

• A history of respiratory diseases, heart disease, vascular disease, central nervous system disorder, psychiatric disorders, hypertension.
• History of any trauma or fracture to the thoracic spine.
• inflammatory diseases such as rheumatoid arthritis, musculoskeletal problem and neurological deficit
• Restrictive respiratory disease, smokers.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: control group	Other: traditional physical therapy exercises for hyperkyphosis; traditional physical therapy exercises for hyperkyphosis
Experimental: study group	Other: diaphragmatic myofascial release with traditional physical therapy exercises for hyperkyphosis; diaphragmatic myofascial release

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
maximum voluntary ventilation	the maximum voluntary ventilation will be measured using spirometer	change from base line at 4 weeks.

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Chest expansion	the chest expansion will be measured using tap measurement	change from base line at 4 weeks.
kyphotic angle	the kyphotic angle will be measured with flexicurve	change from base line at 4 weeks.

Collaborators and Investigators

• Sponsor: Cairo University

Study record dates

Study Major Dates

• Study Start (Estimated): October 10, 2024
• Primary Completion (Estimated): December 20, 2024
• Study Completion (Estimated): December 30, 2024

Study Registration Dates

• First Submitted: September 29, 2024
• First Submitted That Met QC Criteria: September 30, 2024
• First Posted (Actual): October 1, 2024

Study Record Updates

• Last Update Posted (Actual): October 1, 2024
• Last Update Submitted That Met QC Criteria: September 30, 2024
• Last Verified: September 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Musculoskeletal Diseases; Spinal Diseases; Bone Diseases; Spinal Curvatures; Kyphosis
• Other Study ID Numbers: myorelease for hyperkyphosis

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No